Saturday 17 October 2026
Export LSDIF’s income statement to Excel — free account
Lucy Scientific Discovery Inc.
LSDIF Healthcare Drug Manufacturers Specialty & Generic
Operating cash flow growth for three consecutive years.
0.00
0.00
NaN
Follow LSDIF
| Dec '23 | Sep '23 | Jun '23 | Mar '23 | Older periods | |
|---|---|---|---|---|---|
| 337.20% | 631.10% | 0.00% | 0.00% |
+4 more TTM periods Free account |
|
| (249.36%) | (306.88%) | (204.78%) | (171.91%) | ||
ROIC |
0.00% | (168.15%) | (121.70%) | (111.14%) | |
Return on Tangible Assets |
526.00% | (31,115.86%) | (478.87%) | (176.58%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(3.60) | (3.26) | (3.33) | (0.23) | |
Free Cash Flow |
(6.35) | (5.73) | (4.23) | (0.32) | |
Capital Expenditures |
(0.42) | (0.42) | 0.03 | 0.07 | |
| Other line items | |||||
Cash ROIC |
(2,171.19%) | (194.98%) | (66.62%) | (3.39%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | — | — | |
Accounts Payable Turnover |
0.05 | 0.00 | 0.00 | — | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | — | |
Average Days of Payables |
4,581.20 | 3,262.41 | 4,445.77 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | — | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — | |
Interest Coverage |
(5.01) | (1.83) | (1.49) | (2.11) | |
Operating CF/Net income |
0.52 | 0.55 | 0.47 | 0.05 | |
Depreciation/Fixed assets |
0.00 | 0.28 | 0.21 | 0.15 | |
Capex/Depreciation |
(2.88) | (2.29) | 0.21 | 0.54 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(3.36) | (3.02) | (3.36) | (0.28) | |
Capex per Share |
(0.24) | (0.24) | 0.03 | 0.05 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates